About Boehringer Ingelheim China
In 1994 Boehringer Ingelheim entered China with its headquarters in Shanghai. Now it has set up 5 regions nationwide in East China, South China, West China, North China and Beijing with more than 3,000 employees. The total investment in China amounts to around 200 million euros. The major business focuses of BI China include prescription medicine, consumer healthcare, animal health and biopharmaceuticals. BI China established its plant in Zhangjiang High-Tech Park and upgraded it into a global core operation center through expansion. The company aims to bring more and better innovative products to patients in China to enhance their health and life quality.
Facts & Figures
|Number of employees||3500|